Nicholas N Severtsev Selected Research

cyclosomatostatin

1/2021	Anticataleptic activity of nicotine in rats: involvement of the lateral entorhinal cortex.
1/2018	Brain sites mediating cyclosomatostatin-induced catalepsy in Wistar rats: A specific role for the nigrostriatal system and locus coeruleus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas N Severtsev Research Topics

Disease

6	Catalepsy 01/2022 - 01/2012
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Depressive Disorder (Melancholia) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2012

Drug/Important Bio-Agent (IBA)

3	Haloperidol (Haldol)FDA LinkGeneric 01/2022 - 01/2012
3	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 01/2012
2	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 01/2012
2	cyclosomatostatinIBA 01/2021 - 01/2018
1	Histamine H2 ReceptorsIBA 01/2022
1	Ranitidine (Zantac)FDA LinkGeneric 01/2022
1	6- cyclopropylmethyl- 2- (2,4- dichlorophenyl)- 7- ethyl- 4- methyl- 7,8- dihydro- 6H- 1,3,6,8a- tetraazaacenaphthyleneIBA 01/2022
1	CRF receptor type 1IBA 01/2022
1	Diphenhydramine (Benadryl)FDA LinkGeneric 01/2021
1	Nicotine FDA Link 01/2021
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2012
1	Pharmaceutical PreparationsIBA 12/2012
1	Dopamine (Intropin)FDA LinkGeneric 01/2012
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2012

Therapy/Procedure

1	Therapeutics 01/2022